We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

A2M:ASXa2 Milk Company Limited Analysis

Data as of 2026-03-14 - not real-time

A$9.58

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

The stock is trading just above its short‑term moving average and comfortably above both the medium‑ and long‑term averages, confirming a bullish trend. RSI sits in a neutral mid‑range, suggesting balanced momentum, while the MACD histogram is negative with the signal line above the MACD line, indicating a short‑term bearish bias. Current price rests near a well‑defined support level just below today’s price, providing a cushion against downside, and resistance lies close to the 52‑week high, implying limited upside unless a breakout occurs. Volatility over the past month is high and beta is low, reflecting limited systematic risk. The company posted strong revenue growth and solid margins for the sector, with free cash flow supporting a modest dividend and a payout ratio near the mid‑point.
Recent earnings beat and an upgraded FY26 guidance propelled the share price up significantly on the news, reinforcing analyst optimism with a consensus buy rating. However, a discounted cash‑flow model suggests a fair value well below the market price, pointing to an overvalued valuation. The blend of strong fundamentals, positive earnings momentum, and a sustainable dividend makes the stock attractive, but valuation concerns and the bearish MACD signal temper enthusiasm.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Recent earnings beat and guidance upgrade
  • Technical support level near current price
  • Overvalued relative to DCF fair value

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong revenue growth and margin profile
  • Sustainable dividend with healthy cash flow
  • Positive analyst consensus and upgraded guidance

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Brand positioning in premium dairy segment
  • Exposure to multiple geographies balancing growth and risk
  • Valuation premium relative to intrinsic value

Key Metrics & Analysis

Financial Health

Revenue Growth18.80%
Profit Margin5.94%
P/E Ratio38.3
ROE14.72%
ROA8.98%
Debt/Equity1.38
P/B Ratio6.1
Op. Cash FlowA$217.9M
Free Cash FlowA$157.6M

Technical Analysis

TrendBullish
RSI54.6
SupportA$8.76
ResistanceA$9.97
MA 20A$9.61
MA 50A$9.07
MA 200A$8.77
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88

Valuation

Fair ValueA$7.61
Target PriceA$9.62
Upside/Downside0.46%
GradeOvervalued
TypeGrowth
Dividend Yield1.77%

Risk Assessment

Beta0.28
Volatility36.24%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.